These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3349966)

  • 1. Phenytoin levels in catamenial epilepsy.
    Kumar N; Behari M; Ahuja GK; Jailkhani BL
    Epilepsia; 1988; 29(2):155-8. PubMed ID: 3349966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three patterns of catamenial epilepsy.
    Herzog AG; Klein P; Ransil BJ
    Epilepsia; 1997 Oct; 38(10):1082-8. PubMed ID: 9579954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin pharmacokinetics in catamenial epilepsy.
    Shavit G; Lerman P; Korczyn AD; Kivity S; Bechar M; Gitter S
    Neurology; 1984 Jul; 34(7):959-61. PubMed ID: 6429565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catamenial epilepsy: hormonal aspects.
    Verrotti A; Laus M; Coppola G; Parisi P; Mohn A; Chiarelli F
    Gynecol Endocrinol; 2010 Nov; 26(11):783-90. PubMed ID: 20518639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure exacerbation and hormonal cycles in women with epilepsy.
    Kim GH; Lee HW; Park H; Lee SK; Lee SA; Kim YI; Song HK; Shin DJ; Hong SB
    Epilepsy Res; 2010 Aug; 90(3):214-20. PubMed ID: 20542664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on phenytoin pharmacokinetics in 15 patients with refractory epilepsy].
    Pan SQ; Hu ZX; Cai HS
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):290-2, 318. PubMed ID: 1478128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin/clonazepam interaction.
    Saavedra IN; Aguilera LI; Faure E; Galdames DG
    Ther Drug Monit; 1985; 7(4):481-4. PubMed ID: 4082246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy.
    Rościszewska D; Buntner B; Guz I; Zawisza L
    J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):47-51. PubMed ID: 3958732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of carbamazepine and phenytoin in pregnancy.
    Tomson T; Lindbom U; Ekqvist B; Sundqvist A
    Epilepsia; 1994; 35(1):131-5. PubMed ID: 8112235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.
    Herzog AG; Harden CL; Liporace J; Pennell P; Schomer DL; Sperling M; Fowler K; Nikolov B; Shuman S; Newman M
    Ann Neurol; 2004 Sep; 56(3):431-4. PubMed ID: 15349872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ; Haidukewych D; Leheta BJ
    Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting.
    Selioutski O; Grzesik K; Vasilyeva ON; Hilmarsson Á; Fessler AJ; Liu L; Gross RA
    Seizure; 2017 Nov; 52():199-204. PubMed ID: 29073585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical rules for phenytoin dosing.
    Privitera MD
    Ann Pharmacother; 1993 Oct; 27(10):1169-73. PubMed ID: 7818614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
    Liu J; Yu N; Sun H; Liang Y; Xie Y; Chen K
    J Pak Med Assoc; 2015 Jul; 65(7):793-5. PubMed ID: 26160095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
    Bachmann K; Voeller K; Forney R
    Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No gender effect on binding characteristics of phenytoin to serum proteins in monotherapy for adult patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Sep; 7(5):285-9. PubMed ID: 11317172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.